Biography
Primary focus of work is global market development in the predictive genomics space. Engaging with organizations and institutions seeking to implement a full program - from sample collection to physician/patient reporting - using a patient’s whole genome data for common disease risk and ADR (adverse drug reaction) risk prediction. Working to establish a functioning ecosystem and workflows that show healthcare providers a path to implementing such programs system-wide and at scale.
Talk
Implement Predictive Genomics Today, Improve Healthcare’s Tomorrow
Healthcare costs represent an outsized portion of all developed country’s GDP. Predictive genomic posits that keeping populations healthier allows providers to manage patient health rather than manage disease. Risk prediction through whole genome profiling of healthy individuals is the key.